TickerFacts.

A business in context

PFE research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-31 · 0001225208-26-007499

  2. 4 · Ownership change

    Report date 2026-08-14 · 0001225208-26-007145

  3. 4 · Ownership change

    Report date 2026-08-12 · 0001225208-26-007083

  4. 4 · Ownership change

    Report date 2026-08-05 · 0001225208-26-007004

  5. 4 · Ownership change

    Report date 2026-08-05 · 0001225208-26-006944

  6. 4 · Ownership change

    Report date 2026-08-05 · 0001225208-26-006943

  7. 10-Q · Quarterly report

    Report date 2026-06-28 · 0000078003-26-000095

  8. 8-K · Current report

    Report date 2026-08-04 · 0000078003-26-000094 · Items 2.02,9.01

  9. 4 · Ownership change

    Report date 2026-07-31 · 0001225208-26-006900

  10. 4 · Ownership change

    Report date 2026-07-15 · 0001225208-26-006638

  11. 8-K · Current report

    Report date 2026-06-18 · 0000078003-26-000087 · Items 7.01

  12. 8-K · Current report

    Report date 2026-06-18 · 0000078003-26-000085 · Items 5.02,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-29 · 0000078003-26-000054

  14. 8-K · Current report

    Report date 2026-05-05 · 0000078003-26-000053 · Items 2.02,9.01

  15. 8-K · Current report

    Report date 2026-04-23 · 0000078003-26-000044 · Items 5.07

  16. DEF 14A · Proxy statement

    Report date 2026-04-23 · 0000078003-26-000033

  17. 10-K · Annual report

    Report date 2025-12-31 · 0000078003-26-000026

  18. 8-K · Current report

    Report date 2026-02-03 · 0000078003-26-000005 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2025-12-16 · 0000078003-25-000167 · Items 7.01,9.01

  20. 8-K · Current report

    Report date 2025-11-18 · 0001193125-25-291406 · Items 8.01,9.01

  21. 8-K · Current report

    Report date 2025-11-13 · 0000078003-25-000159 · Items 8.01

  22. 10-Q · Quarterly report

    Report date 2025-09-28 · 0000078003-25-000150

  23. 8-K · Current report

    Report date 2025-11-04 · 0000078003-25-000149 · Items 2.02,9.01

  24. 10-Q · Quarterly report

    Report date 2025-06-29 · 0000078003-25-000138

  25. 8-K · Current report

    Report date 2025-08-05 · 0000078003-25-000136 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2025-05-14 · 0001193125-25-122480 · Items 8.01,9.01

  27. 10-Q · Quarterly report

    Report date 2025-03-30 · 0000078003-25-000114

  28. 8-K · Current report

    Report date 2025-04-29 · 0000078003-25-000111 · Items 2.02,2.05,9.01

  29. 8-K · Current report

    Report date 2025-04-24 · 0000078003-25-000109 · Items 5.07

  30. DEF 14A · Proxy statement

    Report date 2025-04-24 · 0000078003-25-000062

  31. 10-K · Annual report

    Report date 2024-12-31 · 0000078003-25-000054

  32. 8-K · Current report

    Report date 2025-02-04 · 0000078003-25-000017 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2024-12-17 · 0000078003-24-000195 · Items 7.01,9.01

  34. 10-Q · Quarterly report

    Report date 2024-09-29 · 0000078003-24-000191

  35. 8-K · Current report

    Report date 2024-10-29 · 0000078003-24-000188 · Items 2.02,9.01

  36. 8-K · Current report

    Report date 2024-10-10 · 0000078003-24-000185 · Items 5.02,9.01

  37. SC 13D/A · Ownership disclosure

    0000078003-24-000183

  38. SC 13D/A · Ownership disclosure

    0000078003-24-000179

  39. SC 13D/A · Ownership disclosure

    0000078003-24-000168

  40. 10-Q · Quarterly report

    Report date 2024-06-30 · 0000078003-24-000166

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 24 transaction rows24AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

25 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-26
2026-06-30
Buckley Mortimer JA · Grant / award
Acquired
Phantom Stock Units
Derivative security
1543.8524.29
2026-06-26
2026-06-30
Echevarria JosephA · Grant / award
Acquired
Phantom Stock Units
Derivative security
1904.0824.29
2026-06-26
2026-06-30
NARAYEN SHANTANUA · Grant / award
Acquired
Phantom Stock Units
Derivative security
2058.4624.29
2026-06-26
2026-06-30
SMITH JAMES CA · Grant / award
Acquired
Phantom Stock Units
Derivative security
1852.6124.29
2026-06-26
2026-06-30
Quincey JamesA · Grant / award
Acquired
Phantom Stock Units
Derivative security
1595.3124.29
2026-06-26
2026-06-30
Taraporevala CyrusA · Grant / award
Acquired
Phantom Stock Units
Derivative security
1543.8524.29
2026-06-15
2026-06-16
BOURLA ALBERTA · Grant / award
Acquired
Phantom Stock Units SSP
Derivative security
23.026.0
2026-06-09
2026-06-10
DAMICO JENNIFER B.S · Sale
Disposed
Common Stock2000.025.7
2026-05-29
2026-06-01
BOURLA ALBERTA · Grant / award
Acquired
Phantom Stock Units SSP
Derivative security
23.026.18
2026-05-15
2026-05-18
BOURLA ALBERTA · Grant / award
Acquired
Phantom Stock Units SSP
Derivative security
24.025.33
2026-04-30
2026-05-04
BOURLA ALBERTA · Grant / award
Acquired
Phantom Stock Units SSP
Derivative security
22.026.7
2026-04-23
2026-04-27
Gottlieb ScottA · Grant / award
Acquired
Phantom Stock Units
Derivative security
7686.5426.67
2026-04-23
2026-04-27
NORA JOHNSON SUZANNE MA · Grant / award
Acquired
Phantom Stock Units
Derivative security
7686.5426.67
2026-04-23
2026-04-27
LITTMAN DAN R.A · Grant / award
Acquired
Phantom Stock Units
Derivative security
7686.5426.67
2026-04-23
2026-04-27
BLAYLOCK RONALD EA · Grant / award
Acquired
Phantom Stock Units
Derivative security
7686.5426.67
2026-04-23
2026-04-27
Buckley Mortimer JA · Grant / award
Acquired
Phantom Stock Units
Derivative security
7686.5426.67
2026-04-23
2026-04-27
Desmond-Hellmann SusanA · Grant / award
Acquired
Phantom Stock Units
Derivative security
7686.5426.67
2026-04-23
2026-04-27
Echevarria JosephA · Grant / award
Acquired
Phantom Stock Units
Derivative security
7686.5426.67
2026-04-23
2026-04-27
NARAYEN SHANTANUA · Grant / award
Acquired
Phantom Stock Units
Derivative security
7686.5426.67
2026-04-23
2026-04-27
Quincey JamesA · Grant / award
Acquired
Phantom Stock Units
Derivative security
7686.5426.67
2026-04-23
2026-04-27
SMITH JAMES CA · Grant / award
Acquired
Phantom Stock Units
Derivative security
7686.5426.67
2026-04-23
2026-04-27
Taraporevala CyrusA · Grant / award
Acquired
Phantom Stock Units
Derivative security
7686.5426.67
2026-04-15
2026-04-17
BOURLA ALBERTA · Grant / award
Acquired
Phantom Stock Units SSP
Derivative security
22.027.19
2026-04-14
2026-04-16
BOURLA ALBERTA · Grant / award
Acquired
Phantom Stock Units SSP
Derivative security
911.027.11
2026-03-31
2026-04-01
BOURLA ALBERTA · Grant / award
Acquired
Phantom Stock Units SSP
Derivative security
21.028.08

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000078003PFIZER INC
G. D. Searle & CompanyPfizer UKWyethPfizer (Japan)Pfizer AktiebolagPfizer (Canada)Pfizer SASPfizer Corporation Austria Gesellschaft mbHPfizer SLPfizer S.R.L.Pfizer (Australia)Pfizer en SuisseWarner–LambertAgouron PharmaceuticalsParke-DavisZoetisHospiraPfizer AGPfizer, spol. s r.o.

Showing 19 of 19 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
765LHXWGK1KXCLTFYQ30
GLEIF legal name
PFIZER INC.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-03-19T12:44:11Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Pfizer · alias · wikidata
  • PFE · alias · wikidata
  • G. D. Searle & Company · subsidiary · wikidata
  • G. D. Searle and Company · subsidiary · wikidata
  • G. D. Searle & Co. · subsidiary · wikidata
  • Searle & Co. · subsidiary · wikidata
  • Searle · subsidiary · wikidata
  • Pfizer UK · subsidiary · wikidata
  • Pfizer Limited · subsidiary · wikidata
  • Wyeth · subsidiary · wikidata
  • Wyeth Pharmaceuticals Inc. · subsidiary · wikidata
  • Pfizer (Japan) · subsidiary · wikidata
  • Pfizer Aktiebolag · subsidiary · wikidata
  • Pfizer AB · subsidiary · wikidata
  • Pfizer (Canada) · subsidiary · wikidata
  • Pfizer SAS · subsidiary · wikidata
  • Pfizer Corporation Austria Gesellschaft mbH · subsidiary · wikidata
  • Pfizer Corporation Austria Ges.mbH · subsidiary · wikidata
  • Pfizer Corporation Austria GmbH · subsidiary · wikidata
  • Pfizer SL · subsidiary · wikidata
  • Pfizer S.L. · subsidiary · wikidata
  • Pfizer S.A. · subsidiary · wikidata
  • Pfizer S.R.L. · subsidiary · wikidata
  • Pfizer SRL · subsidiary · wikidata
  • Pfizer (Australia) · subsidiary · wikidata
  • Pfizer en Suisse · subsidiary · wikidata
  • PFIZER PFE SWITZERLAND GMBH, Pfizer in Switerzland · subsidiary · wikidata
  • Warner–Lambert · subsidiary · wikidata
  • Warner-Lambert Inc · subsidiary · wikidata
  • Warner-Lambert-House · subsidiary · wikidata
  • Lambert Pharmacal Co. · subsidiary · wikidata
  • Lambert Pharmacal · subsidiary · wikidata
  • Lambert Pharmacal Company · subsidiary · wikidata
  • Agouron Pharmaceuticals · subsidiary · wikidata
  • Agouron Pharmaceuticals, Inc. · subsidiary · wikidata
  • Parke-Davis · subsidiary · wikidata
  • Parke, Davis & Company · subsidiary · wikidata
  • Zoetis · subsidiary · wikidata
  • Zoetis Inc. · subsidiary · wikidata
  • Hospira · subsidiary · wikidata
  • Hospira, Inc. · subsidiary · wikidata
  • Pfizer AG · subsidiary · wikidata
  • Pfizer SA · subsidiary · wikidata
  • Pfizer, spol. s r.o. · subsidiary · wikidata
  • Pfizer spol sro · subsidiary · wikidata
  • Pfizer, spol. s.r.o · subsidiary · wikidata
  • Pfizer (Czech Republic) · subsidiary · wikidata
  • PFIZER INC · former SEC name · 1994-03-18 to 2026-09-01
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$63.63B$67.73B
2023-12-31$59.55B$65.26B
2022-12-31$101.17B$115.42B
2021-12-31$81.29B$100.15B
2020-12-31$41.65B$53.74B

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗